NIKKOL GRINNELL: Open Payments
NPI 1962148627 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 54 payments from 21 companies in 2025. Trend: 2023 $903 · 2024 $1,344 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $120 |
| PFIZER INC. | 6 | $105 |
| Novo Nordisk Inc | 5 | $94 |
| Exact Sciences Corporation | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Lilly USA, LLC | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Amgen Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $39 |
Products named: GEMTESA, SPRAVATO, MOUNJARO, XIFAXAN, Wegovy, ELIQUIS, EVENITY, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
